Russell Kevin Klass, Vice President of Sales at Zomedica Corp. (ZOM), bought 700,007 shares at $0.15 ($105K) on 2024-06-11, disclosed to the SEC on 2024-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.15 | 200,007 | $30K | 28.6% |
| 2 | $0.15 | 500,000 | $75K | 71.4% |
| Total | $0.15 avg | 700,007 | $105K | 100% |
| Filing → |
| ZOMDF | BUY | 2025-11-14 | $15K | — | Filing → |
| ZOMDF | BUY | 2025-11-12 | $12K | — | Filing → |
| ZOMDF | BUY | 2025-11-10 | $500 | — | Filing → |